The dihydrochalcone phloretin induced apoptosis in B16 mouse melanoma 4A5 c
ells and HL60 human leukemia cells. Phloretin was suggested to induce apopt
osis in B16 cells mainly through the inhibition of glucose transmembrane tr
ansport. The phloretin-induced apoptosis in B16 tells was inhibited by acti
nomycin D, Ac-YVAD-CHO caspase-1-like inhibitor, and Ac-DEVD-CHO caspase-3-
like inhibitor. During the induction of apoptosis by phloretin, the express
ion of Bar protein in B16 cells increased and the levels of p53, Bcl-2, and
Bcl-X-L proteins did not change. Our results suggested that phloretin indu
ced apoptosis through the promotion of Bar protein expression and caspases
activation. On the other hand, phloretin may induce apoptosis in HL60 cells
through the inhibition of protein kinase C activity because phloretin inhi
bited protein kinase C activity in HL60 cells more than that in B16 cells.
The phloretin induced-apoptosis in HL60 cells was not inhibited by actinomy
cin D and the caspase-1-like inhibitor, but slightly inhibited by the caspa
se3-like inhibitor. Phloretin reduced the level of caspase 3 protein in HL6
0 cells, but not the level of the Bcl-2 protein. Phloretin did not increase
the level of Bar protein. Phloretin was suggested to induce apoptosis in H
L60 cells through the inhibition of protein kinase C activity, followed by
the pathway, which is different from that in B16 cells.